Viking Therapeutics advances its dual GLP-1/GIP obesity drug into Phase 3 trials, entering a $100 billion weight loss market. Applied Digital's $7 billion CoreWeave partnership transforms it into an ...

Trump's housing chief said he had directed Fannie and Freddie to come up with proposals to start counting crypto as an asset ...

There was a pause on Wednesday as investors shift from war speculation to considerations over interest rates and tariffs. A raft of economic data over the next two days could shift markets.